1. (a) O.O. Ajani, O.Y. Audu, D.V. Aderohunmu, F.E. Owolabi, A.O. Olomieja, Am. J. Drug Discovery Dev., 2017, 7, 1-24
2. (b) I. Khan, A. Ibrar, W. Ahmed, A. Saeed, Eur. J. Med. Chem., 2015, 90, 124-169.
3. (a) P. Ghosh, G. Chhetri, A.K. Nandi, S. Sarkar, T. Saha, S. Das,J. Org. Chem. 2018, 83, 12411−12419; (b) P. Ghosh, G. Chhetri, A.K. Nandi, S. Sarkar, T. Saha, S. Das, New J. Chem.,2019, 43, 10959-10964; (c) P. Ghosh, B. Ganguly, B. Kar, S. Dwivedi, S. Das, Syn. Comm., 2018,48, 1076-1084;(d) B. Mandol, P. Ghosh, T.K. Das, M Kundu, S. Das, Org. Biomol. Chem.2021, 19, 360-364; (e) P. Ghosh, G. Chhetri, E. Perl, S. Das, Adv. Synth. Catal.2020,363, 1 –10.
4. (a) K.M. Elattar, B.D. Mert, M. Monier, A. El-MekabatyRSC Adv.,2020, 10, 15461-15492;(b) R.T. Bhawale,A.S. Chillal,U.A. Kshirsagar, J. Het. Chem.2023, 60(8), 1356-1373; (c) M. Mohamed,A.-L. Doaa,E-M. Ahmed, E. Khaled M. Mini-Rev. Org. Chem., 2020, 17(6), 717-739; (d) D.R. Anderson, R.A.Volkmann, F. Menniti, C. Fanger, Y. Xu, PCT Int. Appl.WO2018119374, June 2018.
5. Synthesis and efficacy of 1-[bis(4-fluorophenyl)-methyl]piperazine derivatives for acetylcholinesterase inhibition, as a stimulant of central cholinergic neurotransmission in Alzheimer’s disease